B-cell Activating Factor Polymorphisms in Rheumatoid Arthritis-Associated Atherosclerosis

Area of Science:

• Rheumatology
• Cardiovascular Medicine
• Genetics

Background:

• Rheumatoid Arthritis (RA) is a chronic inflammatory disease impacting joints and increasing cardiovascular disease (CVD) risk.
• Chronic inflammation and genetic factors are key contributors to atherosclerosis in RA patients.
• The precise mechanisms linking RA to accelerated atherosclerosis require further elucidation.

Purpose of the Study:

• To investigate the association between B-cell activating factor (BAFF) gene variants and the pathogenesis of RA-related atherosclerosis.
• To identify potential genetic prognostic markers for cardiovascular complications in rheumatoid arthritis.

Main Methods:

• Analysis of BAFF gene polymorphisms in RA patients and healthy controls using Polymerase Chain Reaction (PCR).
• Assessment of atherosclerosis via carotid and femoral artery ultrasonography to measure plaque formation and mean intima-media thickness (mIMT).
• Correlation of genetic data with clinical, biochemical, and serological markers.

Main Results:

• Genetic variations in BAFF may play a role in the development of atherosclerosis in RA patients.
• Specific BAFF polymorphisms could serve as prognostic markers for cardiovascular disease in RA.
• Ultrasonography revealed associations between genetic profiles and atherosclerotic changes.

Conclusions:

• BAFF gene variants are implicated in the pathogenesis of RA-associated atherosclerosis.
• Identifying these genetic markers could lead to improved risk stratification and targeted therapies for RA patients.
• This research offers new insights into atherosclerotic processes within chronic inflammatory conditions.